World AIDS Day 2001: I Care . . . Do You?
World AIDS Day 2001 is this Saturday, Dec. 1! Check out a listing of upcoming events on TV, on the Web and around the world. Find out what you can do to teach yourself and others about HIV/AIDS, get more deeply involved in the battle against HIV, or help yourself if you are infected.
Visual AIDS' December Web Gallery
The December Visual AIDS Web gallery is now live! This month's gallery is entitled: "Retracing: 20 Years/20 Artists. A Look at Art Through the Age of AIDS." It's curated by Peter Cramer and Jack Waters.
New Hepatitis Expert at The Body's Forums
The Body is pleased to announce a new expert in our Hepatitis and HIV Ask the Expert Forum. Dr. Michael Fried, Associate Professor of Medicine and Director of Clinical Hepatology in the Division of Digestive Diseases at the University of North Carolina at Chapel Hill, will join his distinguished colleagues, Dr. Douglas Dieterich and Dr. Maribel Rodriguez-Torres, to answer your questions!
Learning to Cope with Death
"The descriptions of his decline, in whispered calls from back home, had a dreadfully familiar feel to them. Weight loss at a frightful pace. Losing interest in the world. Suddenly looking very old indeed. Most gay men of a certain age have heard those words, have seen the patient, have buried the friend. This case was different, though. It wasn’t AIDS, it was cancer. And the patient was Dad."
The New Face of HIV Therapy
Read the fascinating report on Dr. Roy (Trip) Gulick's recent discussion of new antiretrovirals and evolving treatment strategies, sponsored by New York's Community Research Initiative on AIDS.
Is Ecstasy a T-Cell Killer?
Researchers in the European Union have been studying the impact of ecstasy on the immune system, and have found some troubling data: A single dose of ecstasy taken orally caused a dramatic fall in subjects' T-cell levels. Read more on this alarming study, from Canadian AIDS Treatment Information Exchange.
The HIV Drug You May Never See
Search for a Cure writes about a potentially life-saving treatment for HIV that may never get out of the lab.
Caution: Nelfinavir and Statins
Researchers have found dangerous interactions between nelfinavir and lipid-lowering drugs, or statins, which can heighten the risk of side effects like fatigue and muscle damage. The amount of Lipitor in the
blood, for instance, nearly doubled when it was taken with nelfinavir, and Zocor levels increased sixfold when taken with nelfinavir.
A Better Way to Predict Drug Resistance
A new study shows that the rate at which HIV disappears from the blood during the first week of therapy accurately predicts a drug regimen's long-term effectiveness in an individual.
HIV Needs Cholesterol
HIV must attach to cholesterol-rich regions of a cell's membrane before it can do its destructive work, researchers at the National Institute of Allergy and Infectious Diseases have discovered. These findings provide a more detailed picture of how HIV travels into and out of cells as well as possible ways to block that travel.
HIV Keeps T-Cells from Fighting Back
New research suggests that, although HIV-specific T-cells persist in infected individuals, high virus levels can diminish the ability of those cells to respond to infection. Read the details from the National Institute of Allergy and Infectious Diseases.
How HIV Drugs Get to Market
Bob Huff takes us inside a meeting of the FDA's advisory committee as it discusses the approval of tenofovir (Viread), in GMHC's Treatment Issues.
How I Fell in Love with HIV Research
Sue Gibson, a nurse research coordinator, reflects back on how she stumbled into the field -- and on why people volunteer for research studies.
Is an AIDS Vaccine Around the Corner?
San Francisco AIDS Foundation takes a look at HIV vaccines: How close are we to getting a vaccine off the ground?
Health-Care Workers and HIV
Since AIDS reporting began 20 years ago, the CDC has documented 57 health-care workers in the U.S. who have tested positive for HIV following occupational exposure to the virus. Read more on this and other news regarding HIV/AIDS among health-care workers.
Tell Your Congresspeople: Increase Funding!
The final fiscal year 2002 HIV/AIDS funding levels will soon be
decided. Please call your senators and representatives and urge them to support the highest funding levels!
Sept. 11's Effect on HIV/AIDS Groups
Housing Works is conducting a quick survey of New York City HIV/AIDS groups to gauge the impact of problems related to the September 11 attacks and the bare-bones state budget. They'll use the results of the survey to advocate with federal, state and local officials for funding to keep the HIV/AIDS system of care strong, to restore state AIDS budget cuts, to prevent new cuts in the future, and to push for new funding wherever possible.
Black Churches Become HIV Activism Centers
In its effort to mobilize black churches to become centers for AIDS education and compassion, The Balm in Gilead is sponsoring the 13th Annual Black Church Week of Prayer for the Healing of AIDS, March 3-9, 2002.
A Selection of the Top HIV/AIDS Stories from Across the Internet
Unprotected Sex Risks Young Lives
From BBC (November 27, 2001)
Sounding the Alarm: East Bay's Teenage 'Town Criers' Use Cameras to Bring New Focus to AIDS
From The San Francisco Chronicle (November 25, 2001)
Explicit AIDS Outreach Questioned
Federal audit examines funding process for programs
From The Washington Blade (November 23, 2001)
Cost-Effectiveness of Syringe Exchange As an HIV Prevention Strategy
From The Journal of AIDS (November 19, 2001)
Swift Action Needed to Prevent Explosive HIV/AIDS Epidemics in Asia
From Journal of the American Medical Association (October 24/31, 2001)
HIV Vaccine Efforts Inch Forward
From Journal of the American Medical Association (October 17, 2001)
Sexual Transmission During the Incubation Period of Primary HIV Infection
Research letter from Journal of the American Medical Association (October 10, 2001)